First Albany Starts Altair Nanotechnologies (ALTI) at Neutral
- Greece, China Issues Weigh on Market Psychology
- Unusual 11 Mid-Day Movers 7/6: (VSAR) (WTW) (EXZN) Higher; (SILC) (BSI) (ALLT) Lower
- Aetna (AET) to Acquire Humana (HUM) for $37 Billion, or $230/Share
- Allergan (AGN) to Acquire Oculeve for $125M Plus Milestone Payments
- All Eyes on Cigna (CI)/Anthem (ANTM) With Aetna (AET)/Humana (HUM) Deal in the Books
First Albany initiates coverage on Altair Nanotechnologies (Nasdaq: ALTI) with a Neutral rating.
You May Also Be Interested In
- UPDATE: UBS Starts EnLink Midstream Partners (ENLK) at Buy
- UPDATE: Morgan Stanley Upgrades Edwards Lifesciences (EW) to Overweight; Bullish on TAVR Market
- Evercore ISI Starts Axovant Sciences (AXON) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!